Literature DB >> 24251389

Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.

Moran Gilat-Frenkel, Anat Boehm-Cagan, Ori Liraz, Xunde Xian, Joachim Herz, Daniel M Michaelson1.   

Abstract

This study investigated the possible role of the ApoE receptors Lrp1 and Apoer2 in mediating the pathological effects of ApoE4 in ApoE-targeted-replacement mice expressing either the human ApoE3 or ApoE4 allele. In this study we show that activation of the amyloid cascade by inhibition of the Aβ-degrading enzyme neprilysin results in upregulation of the ApoE receptor Lrp1 in the CA1 hippocampal neurons of 4-month-old ApoE4 mice, but not in the corresponding ApoE3 or ApoE-deficient (KO) mice. These results are in accordance with the previous findings that activation of the amyloid cascade induces Aβ accumulation in the CA1 neurons of ApoE4 mice, but not in ApoE3 or ApoE-KO mice. This suggests that the apoE4-driven elevation of Lrp1 is mediated via a gain of function mechanism and may play a role in mediating the effects of ApoE4 on Aβ. In contrast, no changes were observed in the levels of the corresponding Apoer2 receptor following the neprilysin inhibition. The ApoE receptors of naive ApoE4 mice were also affected differentially and isoform specifically by ApoE4. However, under these conditions, the effect was an ApoE4-driven reduction in the levels of Apoer2 in CA1 and CA3 pyramidal neurons, whereas the levels of Lrp1 were not affected. RT-PCR measurements revealed that the levels of Apoer2 and Lrp1 mRNA in the hippocampus of naïve and neprilysin-inhibited mice were not affected by ApoE4, suggesting that the observed effects of ApoE4 on the levels of these receptors is posttranscriptional. In conclusion, this study shows that the levels of hippocampal ApoE receptors Lrp1 and Apoer2 in vivo are affected isoform specifically by ApoE4 and that the type of receptor affected is context dependent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24251389      PMCID: PMC4065855          DOI: 10.2174/1567205010666131119232444

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  79 in total

1.  LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation.

Authors:  J Herz; D E Clouthier; R E Hammer
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

Review 2.  LRP in amyloid-beta production and metabolism.

Authors:  Guojun Bu; Judy Cam; Celina Zerbinatti
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

3.  ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum.

Authors:  Haim Belinson; Daniel M Michaelson
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

4.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

Authors:  Shiming Ye; Yadong Huang; Karin Müllendorff; Liming Dong; Gretchen Giedt; Elaine C Meng; Fred E Cohen; Irwin D Kuntz; Karl H Weisgraber; Robert W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

5.  Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Sanh H Luu; Karabi Nandy; Carol A Miller; Harry V Vinters; Wayne W Poon; Karen H Gylys
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

6.  The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein.

Authors:  Y Li; M P Marzolo; P van Kerkhof; G J Strous; G Bu
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

7.  Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

8.  Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.

Authors:  Petra May; Astrid Rohlmann; Hans H Bock; Kai Zurhove; Jamey D Marth; Eike D Schomburg; Jeffrey L Noebels; Uwe Beffert; J David Sweatt; Edwin J Weeber; Joachim Herz
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 9.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

10.  Similarities and differences in structure, expression, and functions of VLDLR and ApoER2.

Authors:  Sunil S Reddy; Teal E Connor; Edwin J Weeber; William Rebeck
Journal:  Mol Neurodegener       Date:  2011-05-09       Impact factor: 14.195

View more
  10 in total

Review 1.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 2.  APOE in the normal brain.

Authors:  Sarah A Flowers; G William Rebeck
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

Review 3.  Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Authors:  Jun Yup Lee; Oana C Marian; Anthony S Don
Journal:  Neuromolecular Med       Date:  2021-02-07       Impact factor: 3.843

Review 4.  The role of APOE on lipid homeostasis and inflammation in normal brains.

Authors:  G William Rebeck
Journal:  J Lipid Res       Date:  2017-03-02       Impact factor: 5.922

Review 5.  Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.

Authors:  Mitsuru Shinohara; Masaya Tachibana; Takahisa Kanekiyo; Guojun Bu
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

Review 6.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

Review 7.  Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.

Authors:  Dunhui Li; Craig Stewart McIntosh; Frank Louis Mastaglia; Steve Donald Wilton; May Thandar Aung-Htut
Journal:  Transl Neurodegener       Date:  2021-05-20       Impact factor: 8.014

Review 8.  ApoE4: an emerging therapeutic target for Alzheimer's disease.

Authors:  Mirna Safieh; Amos D Korczyn; Daniel M Michaelson
Journal:  BMC Med       Date:  2019-03-20       Impact factor: 8.775

Review 9.  Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease.

Authors:  Abdullah Al Mamun; Md Sahab Uddin; Md Fahim Bin Bashar; Sonia Zaman; Yesmin Begum; Israt Jahan Bulbul; Md Siddiqul Islam; Md Shahid Sarwar; Bijo Mathew; Md Shah Amran; Ghulam Md Ashraf; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

10.  The apolipoprotein receptor LRP3 compromises APP levels.

Authors:  Inmaculada Cuchillo-Ibañez; Matthew P Lennol; Sergio Escamilla; Trinidad Mata-Balaguer; Lucía Valverde-Vozmediano; Inmaculada Lopez-Font; Isidro Ferrer; Javier Sáez-Valero
Journal:  Alzheimers Res Ther       Date:  2021-11-02       Impact factor: 6.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.